Post by Galderma

At Galderma, disciplined capital management remains an important part of supporting our long-term growth. Today we announced two complementary steps in this direction.    First, we announced that we have agreed to repurchase shares for CHF 232 million in the context of an accelerated bookbuild offering. The shares will be held in treasury for future use in connection with Galderma's employee participation plans, business development opportunities and/or treasury management.   At the same time, we have announced the successful placement of EUR 500 million Eurobond, which will be listed on the SIX Swiss Exchange. Net proceeds from the transaction will be used to fully repay Galderma’s existing bank term loan issued in connection with our initial public offering in March 2024.    Thank you to our teams, partners and investors for their continued support as we position Galderma for continued growth. Read more: https://lnkd.in/e_cZ4T84